References
- HertDECorrellMBobesCUPhysical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health careWorld Psychiatry201110527721379357
- ParttiKHeliövaaraMImpivaaraOSkeletal status in psychotic disorders: a population-based studyPsychosom Med20107293394020841556
- RennJHYangNPChuehCMLinCYLanTHChouPBone mass in schizophrenia and normal populations across different decades of lifeBMC Musculoskelet Disord200910119118498
- BoltonJMMetgeCLixLPriorHSareenJLeslieWDFracture risk from psychotropic medications: population-based analysisJ Clin Psychopharmacol20082838439118626264
- HowardLKirkwoodGLeeseMRisk of hip fracture in patients with a history of schizophreniaBr J Psychiatry200719012913417267929
- MeaneyAMSmithSHowesODO’BrienMMurrayRMO’KeaneVEffects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophreniaBr J Psychiatry200418450350815172944
- BeckerDLiverOMesterRRapoportMWeizmanAWeissMRis-peridone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patientsJ Clin Psychiatry20036476176612934975
- SugawaraNYasui-FurukoriNFujiiANo association between bone mass and prolactin levels among patients with schizophreniaHum Psychopharmacol20112659660122105774
- HowesODWheelerMMeaneyAMBone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatmentJ Clin Psychopharmacol200525325926115876906
- VancampfortDKnapenJProbstMScheeweTRemansSDe HertMA systematic review of correlates of physical activity in patients with schizophreniaActa Psychiatr Scand201212535236222176559
- KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull1987132612763616518
- WoodsSWChlorpromazine equivalent doses for the newer atypical antipsychoticsJ Clin Psychiatry20036466366712823080
- JungDUKellyDLOhMKBone mineral density and osteoporosis risk in older patients with schizophreniaJ Clin Psychopharmacol20113140641021694624
- XiaoguangCDingchaoYZhuoZThe incidence of Chinese women age related bone mineral density, bone loss, osteoporosis and database-multicenter cooperative projectsChin J Osteoporosis2008144221228
- RossPDHeYEYatesAJBody size accounts for most differences in bone density between Asian and Caucasian womenCalcif Tissue Int1996593392343
- KunimatsuTKimuraJFunabashiHInoueTSekiTThe antipsy-chotics haloperidol and chlorpromazine increase bone metabolism and induce osteopenia in female ratsRegul Toxicol Pharmacol201058336036820709132
- SackettGUnisACrouthamelBSome effects of risperidone and quetiapine on growth parameters and hormone levels in young pigtail macaquesJ Child Adolesc Psychopharmacol201020648949321186967
- LinCHHuangKHChangYCClozapine protects bone mineral density in female patients with schizophreniaInt J Neuropsychopharmacol201215789790622014454
- LeeTYChungMYChungHKChoiJHKimTYSoHSBone density in chronic schizophrenia with long-term antipsychotic treatment: preliminary studyPsychiatry Investig20107278284
- O’KeaneVMeaneyAMAntipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?J Clin Psychopharmacol200525263115643097
- VestergaardPRejnmarkLMosekildeLAnxiolytics, sedatives, antidepressants, neuroleptics and the risk of fractureOsteoporos Int20061780781616520889
- HugenholtzGWHeerdinkERvan StaaTPNolenWAEgbertsACRisk of hip/femur fractures in patients using antipsychoticsBone20053786487016111927